Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 8/20 | 0.53 |
| ▸ | PNP | P00491 | 5/20 | 0.47 |
| ▸ | TK1 | P04183 | 2/20 | 0.47 |
| ▸ | HPRT1 | P00492 | 5/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | EDNRA | P25101 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | HBB | P68871 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1302000 | 0.85 | XDH (0.58) | XDHPNPTK1HPRT1USP2 | |
| SCHEMBL25981845 | 0.81 | XDH (0.57) | XDHPNPTK1HPRT1USP2 | |
| SCHEMBL28320857 | 0.78 | XDH (0.55) | XDHPNPTK1HPRT1USP2 | |
| SCHEMBL10339632 | 0.78 | XDH (0.55) | XDHPNPTK1HPRT1USP2 | |
| SCHEMBL1401469 | 0.77 | XDH (0.53) | XDHPNPTK1HPRT1USP2 | |
| SCHEMBL27667185 | 0.77 | XDH (0.63) | XDHPNPTK1HPRT1USP2 | |
| SCHEMBL986800 | 0.75 | XDH (0.60) | XDHPNPTK1HPRT1USP2 | |
| SCHEMBL41787 | 0.73 | XDH (0.59) | XDHPNPTK1HPRT1USP2 | |
| SCHEMBL15005119 | 0.73 | XDH (0.59) | XDHPNPTK1HPRT1USP2 | |
| SCHEMBL10835122 | 0.72 | XDH (0.61) | XDHPNPTK1HPRT1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110229415-A1 | SEMI-SYNTHETIC ANTIBODIES AS RECOGNITION ELEMENTS | UNIVERSITY OF KENTUCKY | 2011-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110229415-A1 | SEMI-SYNTHETIC ANTIBODIES AS RECOGNITION ELEMENTS | SSB, PNP, ADAR | XDH 87/4885PNP 2/4885TK1 66/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.